Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03138876 · ClinicalTrials.gov registry record · NA
EEG Cap for Identification of Non-Convulsive Status Epilepticus
A NA study of Encephalopathy and Altered Mental Status, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03138876: Completed NA study of Encephalopathy and Altered Mental Status, sponsored by Mayo Clinic.
NCT03138876 is a NA study of Encephalopathy and Altered Mental Status that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 211-participant average among 7 other Encephalopathy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03138876, a NA study of Encephalopathy and Altered Mental Status, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Altered mental status (AMS) is one of the most common reasons for inpatient neurology consultation. Non-convulsive status epilepticus (NCSE) is frequently on the differential diagnosis of the patient with AMS. NCSE becomes more refractory to treatment after one hour of seizure activity, making rapid identification and treatment of NCSE of great clinical importance. Currently, an electroencephalogram (EEG) technologist must be called in from home during non-workday hours in order to obtain a stat EEG. The investigators propose the time required for diagnosis of NCSE at Mayo Clinic can be significantly decreased with rapid placement of an EEG cap by the onsite neurology residents.
Primary Outcome
The difference between EEG Cap results reporting time compared to Standard EEG results reporting time measured in minutes.
Conditions Studied
Interventions
- DEVICE EEG Cap
- DRUG Anti-seizure medication
- PROCEDURE Standard EEG
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-05-30 |
| Est. Completion | 2018-08-16 |
| Phase | NA |
What the finished NCT03138876 record still lists
NCT03138876 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 211-participant average among 7 other Encephalopathy trials with a reported enrollment target (91% lower).
The record links to 5 conditions, with Encephalopathy appearing as the primary indexed condition, and to 3 interventions - of which EEG Cap is the first listed.
NCT03138876 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03138876 about?
NCT03138876 is a clinical study titled "EEG Cap for Identification of Non-Convulsive Status Epilepticus". Altered mental status (AMS) is one of the most common reasons for inpatient neurology consultation. Non-convulsive status epilepticus (NCSE) is frequently on the differential diagnosis of the patient with AMS. NCSE becomes more refractory to treatment after one hour of seizure activity, making rapid...
What is the current status of trial NCT03138876?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-05-30. Estimated completion is 2018-08-16.
What conditions does trial NCT03138876 study?
This clinical trial studies the following conditions: Encephalopathy, Altered Mental Status, Nonconvulsive Status Epilepticus, Subclinical Seizure, Nonepileptic Seizures.
What interventions are being tested in trial NCT03138876?
The interventions under investigation include: EEG Cap (DEVICE), Anti-seizure medication (DRUG), Standard EEG (PROCEDURE).
Who is sponsoring clinical trial NCT03138876?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03138876 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Encephalopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
RECRUITING · NA
-
Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment
COMPLETED · NA
-
RCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies
COMPLETED · NA
-
Healthy Little Eyes
RECRUITING
-
CoMind Early Feasibility Study
RECRUITING
-
Automating Delirium Severity in the ICU
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI